A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond

Noel, MS; Kim, S; Hartley, ML; Wong, S; Picozzi, VJ; Staszewski, H; Kim, DW; Van Tornout, JM; Philip, PA; Chung, V; Ocean, AJ; Wang-Gillam, A

Noel, MS (通讯作者),Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.

CANCER MEDICINE, 2022; 11 (22): 4169

Abstract

Background This trial explores SM-88 used with methoxsalen, phenytoin, and sirolimus (MPS) in pretreated metastatic pancreatic ductal adenocarcinoma (......

Full Text Link